Skip to main content
. 2020 Jul 13;40(7):960–969. doi: 10.1007/s10875-020-00821-7

Table 2.

The performance of various methods for distinguishing between the fatal cases and the survived patients

Variables Cutoff value AUC (95% CI) Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) PLR (95% CI) NLR (95% CI) Accuracy (%)
IL-2R (U/mL) 1220 0.814 (0.755–0.874) 41.18% (27.67–54.68%) 92.15% (90.14–94.16%) 28.00% (17.84–38.16%) 95.48% (93.90–97.06%) 5.25 (3.46–7.95) 0.64 (0.51–0.80) 88.63
IL-6 (pg/mL) 39.5 0.901 (0.860–0.942) 68.63% (55.89–81.36%) 90.41% (88.21–92.61%) 34.65% (25.37–43.93%) 97.49% (96.28–98.71%) 7.15 (5.33–9.61) 0.35 (0.23–0.52) 88.90
IL-8 (pg/mL) 30 0.808 (0.738–0.879) 54.90% (41.25–68.56%) 90.26% (88.05–92.48%) 29.47% (20.31–38.64%) 96.43% (95.00–97.86%) 5.64 (4.02–7.90) 0.50 (0.37–0.68) 87.82
TNF-α (pg/mL) 14.4 0.724 (0.644–0.804) 33.33% (20.40–46.27%) 90.12% (87.89–92.35%) 20.00% (11.50–28.50%) 94.80% (93.10–96.50%) 3.37 (2.15–5.28) 0.74 (0.61–0.90) 86.20
B cells (/μL) 63 0.757 (0.685–0.828) 39.22% (25.82–52.62%) 90.70% (88.53–92.87%) 23.81% (14.70–32.92%) 95.27% (93.64–96.89%) 4.22 (2.79–6.38) 0.67 (0.54–0.84) 87.14
CD4+ T cells (/μL) 323 0.906 (0.860–0.952) 78.43% (67.14–89.72%) 90.41% (88.21–92.61%) 37.74% (28.51–46.96%) 98.26% (97.24–99.28%) 8.18 (6.24–10.72) 0.24 (0.14–0.40) 89.58
CD8+ T cells (/μL) 148 0.905 (0.857–0.953) 72.55% (60.30–84.80%) 90.99% (88.85–93.13%) 37.37% (27.84–46.90%) 97.81% (96.68–98.95%) 8.05 (6.02–10.77) 0.30 (0.19–0.47) 89.72
NK cells (/μL) 81 0.888 (0.834–0.941) 66.67% (53.73–79.60%) 90.55% (88.37–92.74%) 34.34% (24.99–43.70%) 97.34% (96.10–98.59%) 7.06 (5.22–9.54) 0.37 (0.25–0.54) 88.90
Prediction model 0.075 0.956 (0.928–0.984) 90.20% (82.03–98.36%) 90.26% (88.05–92.48%) 40.71% (31.65–49.77%) 99.20% (98.50–99.90%) 9.26 (7.25–11.83) 0.11 (0.05–0.25) 90.26

AUC, area under the curve; PPV, positive predictive value; NPV, negative predictive value; PLR, positive likelihood ratio; NLR, negative likelihood ratio; CI, confidence interval; IL-2R, interleukin-2 receptor; IL-6, interleukin-6; IL-8, interleukin-8; TNF-α, tumor necrosis factor-α